“ Seethamraju said that the Leronlimab trial is
Post# of 148268
(Total Views: 641)
Posted On: 05/22/2020 4:46:21 PM
“ Seethamraju said that the Leronlimab trial is different from the remdesivir drug trial in that remdesivir cannot be given to patients with renal and liver damage, but leronlimab can.”
https://www.norwoodnews.org/bronx-hospitals-l...-covid-19/
https://www.norwoodnews.org/bronx-hospitals-l...-covid-19/
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼